Form 4: Community Health Systems Director James S. Ely III Reports Changes in Beneficial Ownership
SEC Form 4
Director James S. Ely III reports acquisition of common stock through conversion of restricted stock units and stock units, as well as adjustments to holdings in Community Health Systems Inc.
Summary
- On March 1, 2024, James S. Ely III, a director of Community Health Systems Inc. (CYH), reported changes in beneficial ownership of the company's common stock.
- Ely acquired 5,894 shares and 9,756 shares of common stock through the conversion of restricted stock units.
- Ely also acquired 62,718 restricted stock units at a price of $2.87.
- Following these transactions, Ely directly owns 322,843 shares of common stock and indirectly owns 4,990 shares through E5 Investors LLC.
- He also holds various restricted stock units and stock units that will convert to common stock under different vesting schedules and deferral plans.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment about the company's performance.
Positives
- The acquisition of shares by a director could be interpreted positively by investors.
Future Outlook
The document does not contain specific forward-looking statements about the company's future performance, but it does detail the vesting schedules and deferral plans for restricted stock units and stock units, which will result in future issuances of common stock to the reporting person.
Industry Context
This filing is a routine disclosure related to insider transactions and doesn't provide specific insights into broader industry trends. However, insider transactions are often monitored by investors for signals about management's confidence in the company's prospects.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders.
- The vesting schedules and deferral plans for restricted stock units are common compensation practices in the healthcare industry.
Stakeholder Impact
- Shareholders may monitor these filings for insights into management's views on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 2023-09-12 | Date of Power of Attorney execution. |
| 2024-03-01 | Date of the reported transactions (conversion of restricted stock units to common stock and acquisition of restricted stock units). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.